Records containing: LENACAPAVIR

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2026-03-27
CAbotégravir LENacapavir DUal Long Acting). Immuno-virological Monitoring and Safety Assessment of HIV-1 Infected Patients Receiving a Long-Acting Antiretroviral Combination of Cabotegravir and Lenacapavir
CLINICAL_TRIALS study record update · 2026-01-14
Phase II, Pilot Study, Open Label, Multicenter, Evaluating Dual Antiretroviral Therapy With Long-acting Cabotegravir/Lenacapavir